Cardiovascular Journal of Africa: Vol 31 No 5 (September/October 2020)

14 / 64

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 5, September/October 2020 234 AFRICA
literature with a report of 11 new cases. Chest 1976; 69: 630–636.
4. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R.
Clinical significance of coronary arterial ectasia. Am J Cardiol 1976;
37: 217–222.
5. Maehara A, Mintz GS, Ahmed JM, Fuchs S, Castagna MT, Pichard
AD, et al . An intravascular ultrasound classification of angiographic
coronary artery aneurysms. Am J Cardiol 2001; 88: 365–370.
6. Türkmen M, Bitigen A, Esen AM. Coronary artery ectasia. J Med Sci
2006; 26(1): 68–72.
7. Adiloglu AK, Can R, Nazli C, Ocal A, Ergene O, Tinaz G, et al. Ectasia
and severe atherosclerosis: relationships with chlamydia pneumoniae,
helicobacterpylori, and inflammatory markers. Tex Heart Inst J 2005;
32: 21–27.
8. Yilmaz H, Tayyareci G, Sayar N, Gurkan U, Tangurek B, Asilturk R, et
al. Plasma soluble adhesion molecule levels in coronary artery ectasia.
Cardiology 2006; 105: 176–181.
9. Yılmaz H, Sayar N, Yılmaz M, Tangürek B , Cakmak N , Gürkan U, et
al. Coronary artery ectasia: clinical and angiographical evaluation. Arch
Turk Soc Cardiol 2009; 36(8): 530–535.
10. Güleç S, Atmaca Y, Kilickap M, Akyurek O, Aras O, Oral D.
Angiographic assessment of myocardial perfusion in patients with
isolated coronary artery ectasia. Am J Cardiol 2003; 91: 996–999.
11. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR,
et al. Which white blood cell subtypes predict increased cardiovascular
risk? J Am Coll Cardiol 2005; 45(10): 1638–1643.
12. Núñez J, Miñana G, Bodí V, Núñez E, Sanchis J, Husser O, et al. Low
lymphocyte count and cardiovascular diseases. Curr Med Chem 2011;
18(21): 3226–3233.
13. Demir M, Keceoglu S, Melek M. The relationship between plasma
eosinophil count and coronary artery ectasia. Cardiol Res 2013; 4(4–5):
159–164.
14. Ayhan SS, Oztürk S, Erdem A, Ozlü MF, Ozyaşar M, Erdem K, et al.
Relation of neutrophil/lymphocyte ratio with the presence and severity
of coronary artery ectasia. Turk Kardiyol Dern Ars 2013; 41(3): 185–190.
[Article in Turkish].
15. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson
G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of
new-onset atrial fibrillation after coronary artery bypass grafting. Am J
Cardiol 2010; 105(2): 186–191.
16. Yang Z, Zhang Z, Lin F, Ren Y, Liu D, Zhong R, et al. Comparisons
of neutrophil‐, monocyte‐, eosinophil‐, and basophil‐lymphocyte ratios
among various systemic autoimmune rheumatic diseases. APMIS 2017;
125(10): 863–871.
17. Brescia G, Pedruzzi B, Barion U, Cinetto F, Giacomelli L, Martini A,
et al. Are neutrophil-, eosinophil-, and basophil-to-lymphocyte ratios
useful markers for pinpointing patients at higher risk of recurrent
sinonasal polyps? Am J Otolaryngol 2016; 37(4): 339–345.
18. Sasano H, Virmani R, Patterson RH, Robinowitz M, Guccion JG.
Eosinophilic products lead to myocardial damage. Hum Pathol 1989;
20(9): 850–857.
19. Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard
A. The principal eosinophil peroxidase product, HOSCN, is a uniquely
potent phagocyte oxidant inducer of endothelial cell tissue factor activ-
ity: a potential mechanism for thrombosis in eosinophilic inflammatory
states. Blood 2006; 107(2): 558–565.
20. Altas Y, Kurtoglu E, Yaylak B, Baysal E, Ucaman B, Ugurlu HM, et al.
The relationship between eosinophilia and slow coronary flow. Ther Clin
Risk Manag 2015; 11: 1187–1191.
21. Yavuz H, Chee R. A review on the vascular features of the hyperim-
munoglobulin E syndrome. Clin Exp Immunol 2010; 159(3): 238–244.
22. Ames PR, Margaglione M, Mackie S, Alves JD. Eosinophilia and
thrombophilia in Churg Strauss syndrome: a clinical and pathogenetic
overview. Clin Appl Thromb Hemost 2010; 16(6): 628–636.
23. Fuster V, Walsh R, Harrington R. Cardiac catheterization, cardiac angi-
ography and coronary blood flow and pressure measurements. Hurst’s
The Heart, 2004: 471–474.
24. Sadr-Ameli M, Sharifi M. The natural history of ectatic coronary artery
disease. Iranian Heart J 2001; 2: 12–16.
25. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG,
Economides NM, Adamopoulou E, et al. The natural history of aneu-
rysmal coronary artery disease. Heart 1997; 78: 136–41.
26. Rath S, Har-Zahav Y, Battler A, Agranat O, Rotstein Z, Rabinowitz
B, et al. Rate of nonobstructive aneurysmatic coronary artery disease;
angiographic and clinical follow up report. Am Heart J 1985; 109:
785–791.
27. Mattern AL, Baker WP, McHale JJ, Lee DE. Congenital coronary
aneurysms with angina pectoris and myocardial infarction treated with
saphenous vein bypass graft. Am J Cardiol 1972; 30: 906–909.
28. Frithz G, Cullhed I, Bjork L. Congenital localized coronary artery
aneurysm without fistula. Report of a preoperatively diagnosed case.
Am Heart J 1968; 76: 674–679.
29. Aydın M, Tekin IO, Dogan SM, Yildirim N, Arasli M, Sayin MR, et al.
The levels of tumor necrosis factor-alpha and interleukin-6 in patients
with isolated coronary artery ectasia. Mediators Inflamm 2009; 2009 :
106145–106145.
30. Dogan A, Tuzun N, Turker Y, Selahattin A, Selcuk K, Mehmet O, et
al. Matrix metalloproteinases and inflammatory markers in coronary
artery ectasia: their relationship to severity of coronary artery ectasia.
Coron Artery Dis 2008; 19: 559–563.
31. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov
K, Albrecht S, et al. Eosinophils area major intravascular location for
tissue factor storage and exposure. Blood 2007; 109(3): 995–1002.
32. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil
cationic granule proteins impair thrombomodulin function. A potential
mechanism for thromboembolism in hypereosinophilic heart disease. J
Clin Invest 1993; 91(4): 1721–1730.
33. Yoshikawa S, Kayes SG, Parker JC. Eosinophils increase lung microvas-
cular permeability via the peroxidase hydrogen peroxide-halide system.
Bronchoconstriction and vasoconstriction unaffected by eosinophil
peroxidase inhibition. Am Rev Respir Dis 1993; 147(4): 914–920.
34. Rodeghiero F, Castaman G, Ruggeri M, Cazzavillan M, Ferracin G,
Dini E. Fibrinolytic studies in 13 unrelated families with factor XII
deficiency. Haematologica 1991; 76(1): 28–33
35. Demir M, Sentürk M, Kuzeytemiz M. The relationship between eosino-
phil and cardiac syndrome X. Clin Appl Thromb Hemost 2013; 21(4):
325–328.
36. Freeman AF, Holland SM. Clinical manifestations of hyper IgE
syndromes. Dis Markers 2010; 29(3–4): 123–130.
37. Puri R, Dundon BK, Leong DP, Khurana S, Worthley MI.
Hypereosinophilic syndrome associated with multiple coronary aneu-
rysms. Int J Cardiol 2009; 133(1): e43–45.
38. Nelson DH, Sandberg AA, Palmer JG, Tyler FH. Blood levels of
17-hydroxycorticosteroids following the administration of adrenal ster-
oids and their relation to levels of circulating leukocytes. J Clin Invest
1952; 31(9): 843–849.
39. Sudhir K, Ports TA, Amidon TM, Goldberger JJ, Bhushan V, Kane JP,
et al. Increased prevalence of coronary ectasia in heterozygous familial
hypercholesterolemia. Circulation 1995; 91: 1375–1380.
40. Yılmaz M, Kayançiçek H. A new inflammatory marker: elevated mono-
cyte to HDL cholesterol ratio associated with smoking. J Clin Med